by Adaobi Ezeokoli | Jun 20, 2024 | Health Law & Policy, Commentary
The Supreme Court of the United States’ term is wrapping up this month, and, as is custom, they are announcing the decisions in their most controversial cases at the end. The much-anticipated decision on access to mifepristone – a drug that in combination with another...
by Adaobi Ezeokoli | Jun 5, 2024 | Health Law & Policy, Commentary
People leaving incarceration often face a host of health challenges, including high rates of chronic physical and behavioral health conditions, barriers to coverage, and health-related social needs. Of particular concern, during the period following release, this...
by Adaobi Ezeokoli | May 22, 2024 | Health Law & Policy, Commentary
At the end of the last open enrollment period, Affordable Care Act (ACA) marketplace sign-ups were at an all-time high, with over 21 million people choosing a plan. This exceeded last year’s sign-ups (which were also a record high) by 5 million. These unprecedented...
by Adaobi Ezeokoli | May 8, 2024 | Health Law & Policy, Commentary
After a lengthy advocacy battle, the Biden Administration released a final rule last week extending eligibility for Affordable Care Act (ACA) coverage to people enrolled in the Deferred Action for Childhood Arrivals (DACA) program, also known as DACA recipients. Read...
by Adaobi Ezeokoli | May 2, 2024 | Health Law & Policy, Commentary
At long last, the Biden Administration has finalized its rule clarifying the protections laid out in Section 1557 of the Affordable Care Act (ACA), the part of the law that forbids federally funded health care activities and programs from discriminating on the basis...
by Adaobi Ezeokoli | Apr 25, 2024 | Health Law & Policy, News
On April 22, 2024, the Administration released a final rule strengthening privacy and confidentiality protections for reproductive health data under the federal Health Insurance Portability and Accountability Act (HIPAA). This rule is one of the many actions the...
by Adaobi Ezeokoli | Apr 17, 2024 | Health Law & Policy, Commentary
A person’s transition from incarceration back to the community is fraught with competing, complex social and behavioral health needs, as well as staggering rates of overdose and other adverse health events. This period can be especially challenging for people with HIV...
by Adaobi Ezeokoli | Mar 27, 2024 | Health Law & Policy, Commentary
Prescription drug access and pricing have been in the policy spotlight at the federal level over the past few years, with Congress taking unprecedent steps to respond to high prescription drug prices in Medicare through passage of the Inflation Reduction Act (IRA) in...
by Adaobi Ezeokoli | Mar 5, 2024 | Health Law & Policy, News
Through the ACA’s preventive care mandate, most private insurance policies must cover a wide range of preventive services without cost-sharing for beneficiaries. These services include important interventions such as screenings for lung and colorectal cancer,...
by Adaobi Ezeokoli | Feb 21, 2024 | Health Law & Policy, Commentary
Under federal law, the Centers for Medicare and Medicaid Services (CMS), the agency that oversees the Medicare program, can ensure coverage of preventive services under Medicare Part A and Part B through a process called a National Coverage Determination (NCD). CMS...
by Adaobi Ezeokoli | Feb 12, 2024 | Health Law & Policy, Commentary, Students Speaking On...
By Jessica Bushman, HLPC Clinic Student, Fall 2023 My semester in Harvard’s Health Law & Policy Clinic was unparalleled. Alongside the Hepatitis C Advocacy Project team, I worked to develop a set of strategies and tools advocates can use to promote more widespread...
by Adaobi Ezeokoli | Feb 7, 2024 | Health Law & Policy, Commentary
The Inflation Reduction Act (IRA), a sweeping federal law enacted in August 2022, included many provisions aimed at making prescription drugs more affordable under Medicare Part D, the Medicare program that provides prescription drug coverage. Two major changes to...
